Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
1,610.20
+0.50 (0.03%)
Sep 12, 2025, 3:29 PM IST
NSE:SUNPHARMA Revenue
Sun Pharmaceutical Industries had revenue of 138.51B INR in the quarter ending June 30, 2025, with 9.47% growth. This brings the company's revenue in the last twelve months to 537.77B, up 9.28% year-over-year. In the fiscal year ending March 31, 2025, Sun Pharmaceutical Industries had annual revenue of 525.78B with 8.42% growth.
Revenue (ttm)
537.77B
Revenue Growth
+9.28%
P/S Ratio
7.21
Revenue / Employee
12.51M
Employees
43,000
Market Cap
3,878.76B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 525.78B | 40.82B | 8.42% |
Mar 31, 2024 | 484.97B | 46.11B | 10.51% |
Mar 31, 2023 | 438.86B | 52.31B | 13.53% |
Mar 31, 2022 | 386.54B | 51.56B | 15.39% |
Mar 31, 2021 | 334.98B | 6.61B | 2.01% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |
Aurobindo Pharma | 320.25B |
Sun Pharmaceutical Industries News
- 4 days ago - Top stocks to watch today, September 10: Bajaj Auto, Eicher Motors, Yes Bank, Sun Pharma and more - Business Upturn
- 5 days ago - Sun Pharma Halol facility classified as “Official Action Indicated” by US FDA - Business Upturn
- 15 days ago - Nifty 50 top losers this month, August 2025: Adani Enterprises, Shriram Finance, IndusInd Bank, Sun Pharma and more - Business Upturn
- 19 days ago - Sun Pharma share slips 2% as BofA Securities downgrades to underperform, cuts target - Business Upturn
- 19 days ago - Top stocks to buy today: Recommendations for August 26- check list - The Times of India
- 5 weeks ago - Nifty 50 top losers today, August 6: Wipro, Sun Pharma, Jio Financial Services, Tech Mahindra and more - Business Upturn
- 5 weeks ago - Raymond to Dr Reddy's: Textiles, pharma stocks bear tariffs brunt - The Times of India
- 6 weeks ago - Nifty 50 top losers today, August 1: Sun Pharma, Dr. Reddy’s Laboratories, Adani Enterprises, Cipla and more - Business Upturn